News - Regulation, Endo Pharmaceuticals

Filter

Popular Filters

Endo Pharma gets CTL from FDA relating to testosterone drug Aveed

31-05-2013

response letter (CRL) regarding the New Drug Application (NDA) for subsidiary Endo Pharmaceuticals' long-acting…

AveedEndo Health SolutionsEndo PharmaceuticalsMen's HealthNorth AmericaPharmaceuticalRegulationTestosterone

US FDA to allow generic copies of Endo's Opana

13-05-2013

Endo Health Solutions (Nasdaq: ENDP) announced Friday (May 10) that the US Food and Drug Administration…

Endo Health SolutionsEndo PharmaceuticalsGenericsNeurologicalNorth AmericaOpana ERPharmaceuticalRegulation

Actavis confirms patent challenge to Endo's Fortesta

04-03-2013

Generics drug giant Actavis (NYSE: ACT, formerly trading as Watson) has confirmed filing an Abbreviated…

ActavisEndo PharmaceuticalsFortestaGenericsMen's HealthNorth AmericaPatentsRegulation

Endo Pharma sues Mylan over Frova patent infringement

17-08-2011

US generic drugmaker Mylan (Nasdaq: MYL) yesterday confirmed that the company and its subsidiary Mylan…

Endo PharmaceuticalsFrovaFrovatriptan SuccinateGenericsLegalMylan LaboratoriesNeurologicalNorth AmericaRegulation

Back to top